CompletedPhase 2NCT00425802
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Studying Chronic mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Hugo R. Castro-Malaspina, MDMemorial Sloan Kettering Cancer Center
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 61 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2006 – 2016
Study locations (1)
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00425802 on ClinicalTrials.gov